International differences in treatment effects in cardiovascular clinical trials

被引：8

作者：

O'Shea, JC ^{[1
]}

Califf, RM ^{[1
]}

机构：

[1] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA

来源：

AMERICAN HEART JOURNAL | 2001年 / 141卷 / 05期

关键词：

D O I：

10.1067/mhj.2001.115186

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：875 / 880

页数：6

共 18 条

[1] Geographic variability in outcomes within an international trial of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes - Results from PURSUIT [J].

Akkerhuis, KM ;

Deckers, JW ;

Boersma, E ;

Harrington, RA ;

Stepinska, J ;

Mahaffey, KW ;

Wilcox, RG ;

Lincoff, AM ;

Keltai, M ;

Topol, EJ ;

Califf, RM ;

Simoons, ML .

EUROPEAN HEART JOURNAL, 2000, 21 (05) :371-381

[2]

Amant C, 1997, CIRCULATION, V96, P56

[3] COMPARATIVE CASE FATALITY ANALYSIS OF THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL - VARIATION BY COUNTRY BEYOND PREDICTIVE PROFILE [J].

BARBASH, GI ;

MODAN, M ;

GOLDBOURT, U ;

WHITE, HD ;

VANDEWERF, F .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 21 (02) :281-286

[4] A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST) [J].

Califf, RM ;

Adams, KF ;

McKenna, WJ ;

Gheorghiade, M ;

Uretsky, BF ;

McNulty, SE ;

Darius, H ;

Schulman, K ;

Zannad, F ;

HandbergThurmond, E ;

Harrell, FE ;

Wheeler, W ;

SolerSoler, J ;

Swedberg, K .

AMERICAN HEART JOURNAL, 1997, 134 (01) :44-54

[5] Inter-regional differences and outcome in unstable angina - Analysis of the International ESSENCE trial [J].

Fox, KAA ;

Goodman, S ;

Bigonzi, F ;

Le Louer, V ;

Cohen, M .

EUROPEAN HEART JOURNAL, 2000, 21 (17) :1433-1439

[6]

*GLOB UT STREPT TI, 1993, NEW ENGL J MED, V329, P673

[7] A common variant of the endothelial nitric oxide synthase (Glu298→Asp) is a major risk factor for coronary artery disease in the UK [J].

Hingorani, AD ;

Liang, CF ;

Fatibene, J ;

Lyon, A ;

Monteith, S ;

Parsons, A ;

Haydock, S ;

Hopper, RV ;

Stephens, NG ;

O'Shaughnessy, KM ;

Brown, MJ .

CIRCULATION, 1999, 100 (14) :1515-1520

[8] Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes [J].

Kleiman, NS ;

Lincoff, AM ;

Flaker, GC ;

Pieper, KS ;

Wilcox, RG ;

Berdan, LG ;

Lorenz, TJ ;

Cokkinos, DV ;

Simoons, ML ;

Boersma, E ;

Topol, EJ ;

Califf, RM ;

Harrington, RA .

CIRCULATION, 2000, 101 (07) :751-757

[9] Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease [J].

Kong, DF ;

Califf, RM ;

Miller, DP ;

Moliterno, DJ ;

White, HD ;

Harrington, RA ;

Tcheng, JE ;

Lincoff, AM ;

Hasselblad, V ;

Topol, EJ .

CIRCULATION, 1998, 98 (25) :2829-2835

[10] HEMODYNAMIC-RESPONSES TO PROSTACYCLIN (PGI2) IN THE CONSCIOUS SHEEP [J].

KUBO, K ;

KOBAYASHI, T ;

YOSHIMURA, K ;

FUKUSHIMA, M ;

HANDA, K ;

KUSAMA, S ;

SAKAI, A ;

UEDA, G .

JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (12) :1292-1304

← 1 2 →